Zydus Wellness Limited derived nearly 45 percent of FY26 revenue from seasonal products such as Glucon-D and Nycil, which declined 18.8 percent after early and prolonged monsoon rains; Glucon-D held 58.9 percent of the glucose-powder category as of March 2026 and launched Glucon-D Recharge in March to target active hydration and exercise-led consumption.

Quant Small Cap Fund reduced its exposure to Zydus Wellness in September by selling 35,659 shares, holding nearly 89.98 lakh shares compared to 90.33 lakh shares in August.